# Nava Therapeutics

**Canonical:** https://apis.io/providers/nava-therapeutics/  
**Website:** https://navatx.com  
**APIs profiled:** 0

Nava Therapeutics is a life-sciences company developing lipid nanoparticle (LNP) technology for delivering RNA therapeutics precisely to specific organs and cells, aiming to extend genetic medicines to previously untreatable diseases. Surfaced as a portfolio company of GV (Google Ventures) and added to the API Evangelist network, Nava operates in the therapeutics / RNA-delivery sector and, as a private clinical-stage biotech, publishes a corporate marketing site (pipeline, team, newsroom) but no public developer, API, or integration surface at this time.

## Kin Score — 6.7 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 6.7).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 2.4 |
| Commercial Clarity | 10.5 |
| Access Clarity | 10.5 |

Regulatory layer — **Health**: 12.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Nava Therapeutics Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Life Sciences, Biotechnology, Therapeutics, RNA Delivery, Lipid Nanoparticles, Genetic Medicine

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/nava-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.